Cardiff Oncology Inc (CRDF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 91 | 74 | 133 | 86 | 68 |
| Gross Profit | 91 | 74 | 133 | 86 | 68 |
| Operating Expenses | 10,534 | 11,148 | 9,659 | 7,084 | 6,957 |
| Operating Income | -10,443 | -11,074 | -9,526 | -6,998 | -6,889 |
| Other Income | 0 | 81 | 84 | 85 | 132 |
| Pre-tax Income | -10,443 | -10,993 | -9,442 | -6,913 | -6,757 |
| Net Income Continuous | -10,443 | -10,993 | -9,442 | -6,913 | -6,757 |
| Net Income | $-10,443 | $-10,993 | $-9,442 | $-6,913 | $-6,757 |
| EPS Basic Total Ops | -0.24 | -0.25 | -0.25 | -0.17 | -0.17 |
| EPS Basic Continuous Ops | -0.24 | -0.25 | -0.24 | -0.17 | -0.17 |
| EPS Diluted Total Ops | -0.24 | -0.25 | -0.25 | -0.17 | -0.17 |
| EPS Diluted Continuous Ops | -0.24 | -0.25 | -0.24 | -0.17 | -0.17 |
| EBITDA(a) | $-10,194 | $-10,697 | $-8,966 | $-6,426 | $-6,286 |